Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
3671.T
BuySoftmax Co., Ltd · Healthcare · Japan · $53M · Avg Vol: $87K/d
COMPANY DESCRIPTION
Softmax Co., Ltd. develops and sells integrated hospital information systems, specializing in web-based electronic medical record (EMR) software. The company's proprietary web-native architecture allows for real-time, multi-terminal data sharing, making it highly attractive to medium-to-large medical institutions. This specialized focus, combined with high customer switching costs, provides Softmax with a highly defensive and recurring revenue stream.
FINANCIAL SUMMARY (JPY)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 5.1B | 5.3B | 5.4B | 6.9B | 11.1% | 7.0B |
| EPS (JPY) | 17.54 | 18.88 | 20.01 | 23.87 | 10.8% | 21.67 |
| Shares | 23.9M | 24.0M | 24.0M | 24.0M | +0.4% | 24.0M |
| Debt | 1.4B | 1.3B | 1.4B | 2.5B | 22.3% | 2.4B |
| Equity | 2.9B | 3.2B | 3.5B | 3.9B | 10.2% | — |
| Op CF | 179.7M | 232.5M | 664.0M | 388.9M | 29.3% | 226.3M |
| Inv CF | -4.7M | -11.6M | -92.8M | -1.2B | — | — |
| Fin CF | -144.9M | -200.0M | -100.2M | 883.6M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 3671.T are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 3671.T | Softmax Co., Ltd(you) | $53M | 65 | Buy |
| 3939.T | Kanamic Network Co.,LTD | $157M | 75 | Buy |
| 5038.T | eWeLL Co.,Ltd. | $197M | 79 | Buy |
| 4820.T | EM Systems Co., Ltd. | $261M | 56 | Hold |
| 366A.T | Wellness Communications Corporation | $93M | 98 | Strong Buy |
| 3649.T | FINDEX Inc. | $130M | 96 | Strong Buy |
| 4263.T | SUSMED,Inc. | $60M | 18 | Strong Sell |
| 5592.T | Kusurinomadoguchi, Inc. | $196M | 89 | Strong Buy |
| 9438.T | MTI Ltd. | $213M | 90 | Strong Buy |
| 4320.T | CE Holdings Co.,Ltd. | $172M | 97 | Strong Buy |
Peer medians: ROE 8.3% · P/E 16.6x · Gross margin 46.9%